share_log

HC Wainwright & Co. Reiterates Buy on Atossa Therapeuticsto Buy

Benzinga ·  Dec 13 01:25

HC Wainwright & Co. analyst Emily Bodnar reiterates Atossa Therapeutics (NASDAQ:ATOS) from Buy to Buy.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment